vedolizumab
takeda
['vedo', 'vedolizumab', ' vedo', 'ibd']
we re very proud of paola pibiri giving a great presentation #ecco2023 on the work done with and on understanding the mucosal immune responses in vedolizumab (non)response in #ibd 
Gastroenterologist, Translational research, microbiome & integrative omics analyses, host-microbe interactions in the context of IBD and other chronic diseases